Please login to the form below
Innovative Cellular Therapeutics
This page shows the latest Innovative Cellular Therapeutics news and features for those working in and with pharma, biotech and healthcare.
Chinese biotech claims 90% cure rate for CAR-T therapy
Innovative Cellular Therapeutics presents ‘stellar’ immunotherapy data. Chinese company Innovative Cellular Therapeutics (ICT) has said that a small trial of CAR-T immunotherapy in patients with a rare form of leukaemia
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Featured jobs
-
Senior Copywriter
-
Salary TBC
- Senior / Principal Medical Writers wanted - MedComms - Various U...
-
Excellent Remuneration Packages
-
Account Director, Medical Education
-
Salary TBC
- Editorial Assistants - Medical Communications agency - Cheshire
-
Excellent Remuneration Package
- Senior Medical Writer – Medical Communications – North West – In...
-
Excellent Remuneration Package
-
Senior Medical Writer
-
Salary TBC
- Experienced / Senior Medical Writer - Excellent Progression Oppo...
-
Excellent Salary and Benefits on offer
- Senior Account Manager / Account Director - MedComms - London
-
Highly competitive salary &package
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
Subscribe to our email news alerts
- Leading AstraZeneca’s return to growth in Europe
- Eli Lilly shutters UK neuroscience unit, with 80 job losses expected
- Roche reports continued growth in Q3, despite biosimilar competition
- Takeda offloads select portfolio to Acino ahead of Shire takeover
- Bayer/J&J claim new FDA okay for clot drug Xarelto
- CHMP says OK to UCB/Amgen’s Evenity for osteoporosis after appeal
- The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments
- Come meet Valid Insight at booth C2-006 at ISPOR Europe 2019
- Vertex scores FDA approval for CF triple therapy Trikafta
- Seattle Genetics preps filing next year for oral HER2 drug
- Novartis grows in Q3 thanks to stellar performance of key drugs
- AZ’s Farxiga gets heart failure prevention okay from FDA
PMHub
Kendle Healthcare
Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...
Latest intelligence
- The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments
- The essential medicine list (EML) contains treatments considered to be the most effective and safe in targeting global health concerns. On 9 July 2019, the World Health Organization (WHO) published...
- Evolution or revolution: the latest review of NICE methods
- By Leela Barham...
- Integrating patient reported outcomes into clinical trials
- How capturing the patient voice is unlocking medicines’ commercial potential...
Quick links
Infographics
